Dynamic Technology Lab Private Ltd reduced its position in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 68.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,387 shares of the company's stock after selling 3,043 shares during the period. Dynamic Technology Lab Private Ltd's holdings in Molina Healthcare were worth $457,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Rothschild Investment LLC boosted its holdings in shares of Molina Healthcare by 126.3% during the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after buying an additional 48 shares during the period. Zions Bancorporation National Association UT bought a new stake in Molina Healthcare in the 1st quarter valued at $29,000. Deseret Mutual Benefit Administrators boosted its holdings in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after purchasing an additional 34 shares during the period. Elequin Capital LP boosted its holdings in Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after purchasing an additional 58 shares during the period. Finally, Silver Oak Securities Incorporated bought a new stake in Molina Healthcare in the 1st quarter valued at $34,000. 98.50% of the stock is owned by institutional investors.
Insider Activity at Molina Healthcare
In other news, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO James Woys purchased 10,000 shares of the stock in a transaction dated Monday, August 4th. The shares were acquired at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer owned 74,331 shares in the company, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.26% of the stock is owned by insiders.
Molina Healthcare Price Performance
MOH traded up $2.07 during midday trading on Wednesday, hitting $178.52. The company had a trading volume of 136,439 shares, compared to its average volume of 1,023,031. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market capitalization of $9.68 billion, a PE ratio of 8.78 and a beta of 0.54. Molina Healthcare, Inc has a twelve month low of $151.95 and a twelve month high of $359.97. The firm's 50-day simple moving average is $177.21 and its 200-day simple moving average is $264.38.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported $5.48 EPS for the quarter, missing the consensus estimate of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business had revenue of $11.43 billion for the quarter, compared to analyst estimates of $10.94 billion. During the same quarter in the prior year, the firm earned $5.86 EPS. The firm's quarterly revenue was up 15.7% compared to the same quarter last year. Equities research analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the stock. Sanford C. Bernstein reduced their price target on shares of Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating for the company in a report on Friday, September 5th. Mizuho decreased their price objective on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating on the stock in a report on Friday, July 11th. JPMorgan Chase & Co. decreased their price objective on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating on the stock in a report on Tuesday, July 29th. Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Finally, Barclays reduced their price objective on shares of Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating for the company in a report on Thursday, September 4th. Three research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and a consensus price target of $225.18.
View Our Latest Research Report on Molina Healthcare
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.